Related Experiment Videos
Hepatotoxicity associated with the new antidepressants
Alfonso Carvajal García-Pando1, Javier García del Pozo, Ana Sánchez Sánchez
1Instituto de Farmacoepidemiología de la Universidad de Valladolid, Spain. carvajal@ife.uva.es
The Journal of Clinical Psychiatry
|March 5, 2002
Summary
Nefazodone, an antidepressant, showed a significantly higher incidence of liver injury compared to other antidepressants. Physicians should monitor for drug-induced hepatitis and consider early discontinuation when suspected.
Area of Science:
- Pharmacovigilance
- Hepatology
- Psychiatry
Background:
- Antidepressants, both classical and novel, have known safety profiles, including potential hepatotoxicity.
- Recent reports suggest an increased risk of severe hepatic injury with newer antidepressants.
- Quantifying the risk of antidepressant-induced hepatotoxicity is crucial.
Purpose of the Study:
- To estimate the cumulative incidence of hepatic adverse reactions associated with antidepressant use.
- To compare the risk of hepatotoxicity among different antidepressant medications.
Main Methods:
- Utilized data from the Spanish Pharmacovigilance System for reported hepatic damage cases.
- Employed drug sales data from the Spanish National Health System to estimate patient exposure.
- Calculated the cumulative incidence of hepatic adverse reactions per 100,000 patient-years.
Main Results:
- Most antidepressants studied showed similar reported incidences of liver injury, ranging from 1.28 to 4.00 cases per 100,000 patient-years.
- Nefazodone exhibited a markedly higher incidence of hepatic adverse reactions at 28.96 cases per 100,000 patient-years.
- The reported incidence for nefazodone significantly exceeded that of other studied antidepressants.
Conclusions:
- The incidence of hepatic adverse reactions associated with nefazodone appears higher than previously estimated.
- Physicians should maintain a high index of suspicion for drug-induced hepatitis in patients taking antidepressants.
- Early discontinuation of the offending antidepressant is recommended if hepatitis is suspected.